Yang R, Gombart A F, Serrano M, Koeffler H P
Division of Hematology/Oncology, University of California, Los Angeles 90048, USA.
Cancer Res. 1995 Jun 15;55(12):2503-6.
Several point mutations of p16INK4a were studied by site-specific mutagenesis and functional analysis to assess the effects of these mutations on the function of the protein. These mutations were reported in several malignancies. Three deletional mutants of p16INK4a were also analyzed to reveal the relationship between p16INK4a and p15INK4b and to test the importance of the ankyrin repeats observed in both proteins. We studied the activity of these mutants using the yeast two-hybrid system and an in vitro kinase assay. Our results suggest that point mutations in the conserved ankyrin consensus affect the activity of p16INK4a. However, not all of the point mutations observed in tumors have a detectable effect on the activity. The COOH-terminal region of p16INK4a is not required for the protein to bind and to inhibit CDK4, but the deletion of the 4th ankyrin repeat abolished the activity completely.
通过定点诱变和功能分析研究了p16INK4a的几个点突变,以评估这些突变对蛋白质功能的影响。这些突变在几种恶性肿瘤中都有报道。还分析了p16INK4a的三个缺失突变体,以揭示p16INK4a与p15INK4b之间的关系,并测试在这两种蛋白质中观察到的锚蛋白重复序列的重要性。我们使用酵母双杂交系统和体外激酶测定法研究了这些突变体的活性。我们的结果表明,保守的锚蛋白共有序列中的点突变会影响p16INK4a的活性。然而,并非在肿瘤中观察到的所有点突变都对活性有可检测的影响。p16INK4a的COOH末端区域对于蛋白质结合和抑制CDK4不是必需的,但第4个锚蛋白重复序列的缺失完全消除了活性。